NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$3.87
0.01 (0.26%)
▲
5d:
+8.71%
30d:
-16.23%
90d:
+79.17%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 17, 2026
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NRXP shows positive signals but monitor for confirmation. Market pricing in 9.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: NRXP shows positive signals but monitor for confirmation. Market pricing in 9.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.22
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.48
13.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $3.87, which is considered fair relative to its 30-day fair value range of $3.61 to $4.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.7) compared to its historical average (10.3). Remarkably, the market is currently pricing in an annual earnings decline of 9.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $3.45, while resistance sits at $5.05.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.00 (+985.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $3.45, while resistance sits at $5.05.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.00 (+985.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.61 -
$4.35
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 985.3% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$3.61 -
$4.35
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.45
Resistance Level
$5.06
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.74
Wall Street Target
$42.00
(+985.3%)
Valuation Discount vs History
-9.0% cheaper
PE vs Historical
7.7 vs 10.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.0%
(market-implied from PE analysis)
1-Year Target
$3.52
(-9%)
2-Year Target
$3.20
(-17%)
3-Year Target
$2.92
(-25%)
3-Yr Target (if PE normalizes)
(PE: 8→10)
$3.88
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.7 to 10.3
Stabilization Target:
$5.15
(+33.1%)
PE Expansion Potential:
+33.1%
Share & Embed Analysis
Last updated: July 03, 2026 11:24 PM ET
Data refreshes hourly during market hours. Next update: 12:24 AM
Data refreshes hourly during market hours. Next update: 12:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 64 BUY |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
